Stock·NYSE·Consumer Cyclical
XPeng Inc. (XPEV)
- Market cap
- $9.23B
- Dividend yield
- 0.00%
- Street target
- $18.11median of 25 analysts
- 52-week range
- $9.18 $28.24
The short version
Where XPEV stands today, in four lines, and what CleaRank Financial AI makes of it.
XPEV at a glance
XPeng Inc. (XPEV): Buy, 71/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($10.69 and $15.03).
Figures as of October 16, 2026.
CleaRank Financial AI
XPeng Inc. (XPEV) is currently trading at $9.405, well below its 50-day and 200-day moving averages ($10.69 and $15.03), indicating a bearish technical trend.
The company's earnings per share (EPS) are negative at -$0.45, contributing to a negative profit margin of -4.14%. Despite these fundamental challenges and a bearish RSI of 37.85, Wall Street analysts maintain a consensus 'Buy' rating with a median price target of $18.11, suggesting a significant 92.5% upside potential. Analysts forecast positive EPS in the next fiscal year, a notable turnaround from current losses. This divergence between current negative profitability and future growth expectations, coupled with strong analyst conviction, forms the basis for the optimistic outlook.
Only on CleaRank
Figures we compute ourselves from XPEV's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $9.41 is 12.0% below the 50-day simple moving average of $10.69.Price above its 200-day average ›
The price is 37.4% below the 200-day simple moving average of $15.03.50-day average above the 200-day ›
The 50-day average ($10.69) is 28.9% below the 200-day average ($15.03), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 1% of its 52-week range, between $9.18 and $28.24.
XPEV share price
Pick a period: each tab shows how far XPEV has moved over it, to the last close.
Today's trading
Where XPEV sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
1/2P/S below the sector median ›
The price-to-sales ratio of 0.82 is 56.9% below the sector median of 1.9.Profitable over the last 12 months ›
Net income over the last 12 months was $-466.0M on revenue of $11.3B, a net margin of -4.1%.
Key statistics
The headline figures for XPEV.
As of October 16, 2026, XPEV trades at $9.41, with a market value of $9.23B and no P/E ratio (its trailing earnings are negative).
What the numbers say
CleaRank Financial AI's reading of XPEV's valuation, growth and risks.
XPeng Inc. is currently valued with a price-to-sales ratio of 0.82, which is below the sector average of 1.9, indicating a potential valuation discount relative to its revenue.
However, the company is loss-making, with a negative net profit margin of -4.14% and a negative return on equity of -10.88%, contrasting sharply with the sector's average ROE of 12.4%. The company's debt-to-equity ratio stands at 0.99, which is in line with the sector average of 0.99. While the valuation metrics relative to sales appear attractive, the persistent losses and negative profitability raise concerns about the sustainability of its operations without further capital infusion or a significant turnaround in its business model.
XPEV against the Consumer Cyclical sector
How XPEV compares with the median Consumer Cyclical stock CleaRank tracks.
Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, XPEV trades at 0.8187x, -57% versus the sector average of 1.90x.
Return vs VCR: Since May 5, 2025, XPEV has lost 51.7% against a gain of 15.2% for VCR.
Performance against VCR
XPEV and the Consumer Cyclical sector fund over the same days.
Revenue and earnings
How much XPEV sells, and how much of it becomes profit.
Revenue growth: Revenue grew 87.7% in FY2025 to CN¥76.7B, from CN¥40.9B a year earlier.
Profit margin: The net margin was -1.5% in FY2025, up from -14.2% the year before.
Loss-making: XPEV lost CN¥1.1B in FY2025.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 37.9, showing bearish momentum without being oversold.RSI above 50 ›
An RSI of 37.9 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of XPEV
The score, the reasoning behind it, and what could move the price next.
XPeng Inc. exhibits bearish technical momentum, with its current price of $9.405 trading below both its 50-day SMA ($10.69) and 200-day SMA ($15.03).
The 14-day RSI is at 37.85, indicating bearish momentum and suggesting the stock is not currently overbought. Key support levels are not clearly defined given the downward trend, while resistance is observed at the moving averages. The overall chart structure points to continued downward pressure unless a significant catalyst emerges to reverse the trend.
Positive Next Year EPS and Revenue Growth Estimates ›
Analysts project XPeng Inc. to achieve positive EPS in the next fiscal year and significant revenue growth of 26.00%, indicating a potential turnaround and expansion.
Source: Wall Street EstimatesHigh Analyst Price Target ›
The median analyst price target for XPeng Inc. is $18.11, representing a 92.5% upside from the current price, reflecting strong conviction from the analyst community.
Source: Wall Street EstimatesAttractive Price-to-Sales Ratio ›
XPeng Inc.'s price-to-sales ratio of 0.82 is below the sector average of 1.9, suggesting that the stock may be undervalued relative to its revenue generation.
Source: Company Fundamentals
Bearish Technical Momentum ›
XPeng Inc. is trading below its 50-day and 200-day moving averages ($10.69 and $15.03), with a bearish RSI of 37.85, indicating a downward trend and potential for further price declines.
Source: Technical AnalysisCurrent Profitability Concerns ›
XPeng Inc. is currently loss-making with negative profit margins and return on equity, which contrasts unfavorably with sector averages.
Source: Company Fundamentals
- The stock is trading below its 50-day and 200-day moving averages ($10.69 and $15.03), indicating bearish momentum. A sustained move above the 50-day SMA at $10.69 would be a key technical signal to watch for a potential trend reversal.
Technical indicators
Momentum and trend for XPEV, from its daily closes.
As of October 16, 2026, with XPEV at $9.41, its 14-day RSI is 37.9 (showing bearish momentum without being oversold), its 50-day simple moving average is $10.69 and its 200-day is $15.03.
Calculated by CleaRank on daily closes as of October 16, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What XPEV moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 16, 2026, XPEV's 1-year correlation of daily returns is +0.24 with S&P 500 (SPY), +0.24 with Nasdaq 100 (QQQ), +0.15 with Bitcoin (BTC) and +0.16 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
19 of 25 analysts rate it a buy or strong buy, 4 a hold and 2 a sell.Median target above the price ›
The median 12-month target of $18.11 is 92.5% above the price.More buy ratings than three months ago ›
19 of 25 rate it a buy now, against 21 of 26 three months ago.
XPEV Wall Street View
12-month price targets
The price, $9.41, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Sep 29, 2026 | JP Morgan | Downgrade | Neutral |
| Aug 26, 2026 | Barclays | Maintains | Underweight |
| Aug 25, 2026 | JP Morgan | Maintains | Overweight |
| Jul 16, 2026 | Barclays | Maintains | Underweight |
| May 29, 2026 | Macquarie | Upgrade | Outperform |
As of October 16, 2026, 25 Wall Street analysts cover XPEV: 19 rate it a buy or strong buy, 4 a hold and 2 a sell or strong sell. Their 12-month price targets range from $11.55 to $25.32, with a median of $18.11, 92.5% above the price of $9.41.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
XPEV trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from XPEV's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much XPEV tends to move, against the market and on its own.
The long record
XPEV's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
0/4Average daily move under 2% ›
The price has moved 2.11% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 88.8%, from November 2020 to November 2022; the price is still 84.0% below that peak.Most 1-year holds ended higher ›
37% of 1-year holding periods in the last 6 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in August 2020 is now worth $4,538.17, against $24,112 in the S&P 500 (SPY).
XPEV Drawdowns & Recovery
As of October 16, 2026, XPEV's worst peak-to-trough fall over the last 6 years with dividends reinvested was -88.8% (November 2020 to November 2022); it is still 84.0% below that peak, and 37% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into XPEV in August 2020 is worth now, against the same amount in the S&P 500.
Against the market: XPEV trailed the S&P 500 over this period: $4,538.17 against $24,112.
A $10,000 investment in XPEV in August 2020 would be worth about $4,538 today with dividends reinvested, compared with about $24,112 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to XPEV, and which have not.
Strongest month, November: an average of +36.79%, up in 4 of 6 years.
Weakest month, September: an average of -7.49%, up in 1 of 7 years.
This month, October: has averaged -0.64%, up in 4 of 6 years. Past seasonality does not repeat on schedule.
Over the last 7 years, XPEV's strongest calendar month has been November (average +36.79%, up in 4 of 6 years) and its weakest September (average -7.49%, up in 1 of 7 years).
Average return for each calendar month over the last 7 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in XPEV, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in XPEV today could grow to about $6,702 by 2036 in the base case, with a 90th-percentile outcome near $50,846 and a 10th-percentile outcome around $883. Projections are statistical simulations, not guarantees.
XPEV Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $8.01 for XPEV by 2030 in the base case, from $9.41 today (0.9x over 4 years). The 10th-percentile path ends near $2.22. These are outcomes of a Monte Carlo simulation run on XPEV's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $4.76 | $9.04 | $17.15 | |
| 2028 | $3.51 | $8.68 | $21.49 | |
| 2029 | $2.75 | $8.34 | $25.31 | |
| 2030 | $2.22 | $8.01 | $28.87 | |
| 2031 | $1.84 | $7.70 | $32.27 |
Method: a lognormal simulation of XPEV's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Questions people ask
Answered from the figures on this page, as of October 16, 2026.